Clinical Trial Results While still in development, Retatrutide has shown remarkable results in Phase 2 clinical trials
Scalp Defense: Anti-Inflammatory & Antioxidant Shield A "toxic" scalp environment characterized by chronic inflammation and oxidative stress can lead to premature hair shedding
The drug is also meant to assist overweight adults who also have weight-related conditions, such as high blood pressure, high cholesterol, or Type 2 diabetes, to lose weight
Quick Answer: Tirzepatide may not work effectively due to inadequate dosing, poor medication adherence, advanced beta-cell dysfunction, severe insulin resistance, improper injection technique, or unrealistic expectations about treatment timelines and outcomes
For some patients, complications can be serious
Clinicians should set individualised weight loss targets that balance metabolic benefits with the maintenance of physical function and quality of life